We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking INBX? Get live short interest, options flow, and signals on ORTEX.Sign up free →
IN

Inhibrx Biosciences, Inc. (INBX) short interest & options flow

NASDAQ

Inhibrx Biosciences enters its November 13 earnings window with one of the more striking insider-buying patterns in the biotech space right now, set against a short position that remains stubbornly large and shows no sign of unwinding. The most notable fact about this stock is what the CEO has been doing with his own money. Mark Lappe made multiple open-market purchases on October…

Latest pulse15 May 2026

INBX short interest surges 34% in one week to 18.8% of float, driven by positioning ahead of earnings on May 15.

$84.52+5.28% 1d+17.75% 1w-9.52% 1mClose: 6 Nov 2026
Short interest % of float
High
Live SI on ORTEX →
Cost to borrow
Low
Live CTB on ORTEX →
Market cap
$1.24B
Next earnings
13 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 8 Nov 2026

ORTEX chart of Inhibrx Biosciences, Inc. (INBX) share price and short interest (% of free float), six months to November 6, 2026

INBX news and analysis

RSS

No long-form analysis yet for INBX. Pulse alerts and the live data picture are available on ORTEX.

Open INBX on ORTEX →

Want the live picture for INBX?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for INBX — free to start on ORTEX.

Sign up for free →Open INBX on ORTEX